We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 41-60 of 10,000 results
  1. Lixisenatide in early parkinson’s disease: efficacy, safety, and future directions: a correspondence

    Parkinson’s disease (PD) presents as a complex neurodegenerative disorder characterized by motor and non-motor symptoms, resulting from dopaminergic...

    Hamza Irfan, Siraj Ul Muneer, ... Sana Iftikhar in Neurosurgical Review
    Article 24 May 2024
  2. Pharyngeal adaptation to bolus properties in patients with Parkinson’s disease

    Purpose

    Dysphagia is common in people with Parkinson’s disease (PD). Yet, literature describing swallow function in PD using high-resolution manometry...

    Shakeela Saleem, Anna Miles, Jacqueline Allen in European Archives of Oto-Rhino-Laryngology
    Article Open access 12 June 2024
  3. Serum salusin-α and -β levels in patients with parkinson’s disease

    Background

    The etiology of Parkinson’s disease (PD) is not well known and there is increasing evidence that oxidative stress also plays an important...

    Fatma Ebru Algul, Emine Koc, Hatice Tosun Kaya in Neurological Sciences
    Article 05 September 2023
  4. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease

    Introduction

    Ethnicity differences are an important determinant in the clinical manifestation of Parkinson’s disease (PD), but they are not yet widely...

    Carlo Cattaneo, Jaime Kulisevsky in Advances in Therapy
    Article Open access 09 December 2023
  5. Sympathetic dysfunction as an early indicator of autonomic involvement in Parkinson’s disease

    Purpose

    The specific characteristics of autonomic involvement in patients with early Parkinson’s disease (PD) are unclear. This study aimed to...

    Jin-Woo Park, Luis E. Okamoto, ... Italo Biaggioni in Clinical Autonomic Research
    Article 23 April 2024
  6. Gender differences in non-motor fluctuations in Parkinson’s disease

    Non-motor symptoms (NMS) and Non-motor fluctuations (NMF) in Parkinson’s Disease (PD) are common, involving several domains and affecting quality of...

    Giulia Donzuso, Calogero Edoardo Cicero, ... Alessandra Nicoletti in Journal of Neural Transmission
    Article Open access 01 August 2023
  7. Impact of autonomic symptoms on the clinical course of Parkinson’s disease

    Purpose

    Patients with Parkinson’s disease (PD) exhibit various degrees of autonomic symptoms, which may be associated with Lewy body pathology...

    Hiroaki Fujita, Keitaro Ogaki, ... Keisuke Suzuki in Neurological Sciences
    Article 24 February 2024
  8. Research progress in the early diagnosis of Parkinson’s disease

    Parkinson’s disease is the second major neurodegenerative disease with increasing incidence and population in the world year by year. The...

    LinLin Xie, LuDong Hu in Neurological Sciences
    Article 11 August 2022
  9. Association of health behaviors with function and health-related quality of life among patients with Parkinson’s disease

    Background

    Current evidence on chronic conditions favors promotion of health behaviors as a mean to positively impact health outcomes. In Parkinson’s...

    Michal Duvdevani, Galit Yogev-Seligmann, ... Michal Kafri in Israel Journal of Health Policy Research
    Article Open access 03 January 2024
  10. Association of activities of daily living, mobility and balance ability, and symptoms of Parkinson’s disease with the masses and amounts of intramuscular non-contractile tissue of the trunk and lower extremity muscles in patients with Parkinson’s disease

    Purpose

    We examined the association of activities of daily living (ADL), mobility and balance ability, and symptoms of Parkinson’s disease (PD) with...

    Mitsuhiro Masaki, Moeka Takeuchi, ... Shunsuke Obinata in Journal of Medical Ultrasonics
    Article 30 August 2023
  11. Axial postural abnormalities and pain in Parkinson’s disease

    Axial postural abnormalities and pain are two main determinants of poor quality of life in patients with Parkinson’s disease (PD). Indeed, a detailed...

    Mohammad Al-Wardat, Christian Geroin, ... Silvia Natoli in Journal of Neural Transmission
    Article 23 December 2022
  12. Directional versus ring-mode deep brain stimulation for Parkinson’s disease: protocol of a multi-centre double-blind randomised crossover trial

    Background

    The effectiveness of Deep Brain Stimulation (DBS) therapy for Parkinson’s disease can be limited by side-effects caused by electrical...

    Timo R. ten Brinke, Hannah Jergas, ... Rob M. A. de Bie in BMC Neurology
    Article Open access 18 October 2023
  13. Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol

    Background

    Parkinson’s disease (PD) is a neurodegenerative disease for which no disease-modifying therapies exist. Preclinical and clinical evidence...

    Jules M. Janssen Daalen, Marjan J. Meinders, ... Bastiaan R. Bloem in BMC Neurology
    Article Open access 22 June 2024
  14. Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease

    Background

    Although apathy and impulse control disorders (ICDs) are considered to represent opposite extremes of a continuum of motivated behavior...

    Gianpaolo Maggi, Francis Loayza, ... Ignacio Obeso in Journal of Neurology
    Article Open access 28 February 2024
  15. Association between fatigue and MDS-UPDRS in individuals with Parkinson’s disease: cross-sectional study

    Background

    Fatigue is significant in the context of Parkinson’s disease (PD), considering that one-third of patients classify it as the most...

    Marcelle Brandão Terra, Josiane Lopes, ... Suhaila Mahmoud Smaili in Neurological Sciences
    Article 26 March 2024
  16. Correlation between the MNCD classification-based staging of Parkinson’s disease and quality of life: a cross-sectional study

    Parkinson’s disease (PD) is a highly heterogeneous neurodegenerative disorder with varying clinical subtypes. Recently, a novel classification called...

    Guixiang He, Jingru Ren, ... Ming Lu in Journal of Neural Transmission
    Article Open access 28 March 2024
  17. Prediction of Parkinson’s disease by transcranial sonography-based deep learning

    Objectives

    Transcranial sonography has been used as a valid neuroimaging tool to diagnose Parkinson’s disease (PD). This study aimed to develop a...

    Chang Wei Ding, Ya Kun Ren, ... Chun Feng Liu in Neurological Sciences
    Article 20 November 2023
  18. Association between major dietary patterns and Parkinson’s disease risk: a case–control study

    Background

    There has been emerging attention to investigate the possible role of some dietary factors in the pathogenesis of Parkinson’s disease (PD);...

    Nafiseh Shokri-Mashhadi, Reza Ghiasvand, ... Akram Banijamali in Neurological Sciences
    Article 23 November 2023
  19. Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study

    Introduction

    The DYSCOVER study was a phase 3b, open-label, randomized trial (NCT02799381) that evaluated levodopa-carbidopa intestinal gel (LCIG)...

    Eric Freire-Alvarez, Paola Vanni, ... Olga Sánchez-Soliño in Neurology and Therapy
    Article Open access 12 February 2024
  20. Retinal functional and structural changes in patients with Parkinson’s disease

    Background

    Visual dysfunction have been well reported as one of the non-motor symptoms in Parkinson’s disease (PD). The aim of this study was to...

    Rehab Elanwar, Hatem Al Masry, ... Mohammed M. Masoud in BMC Neurology
    Article Open access 18 September 2023
Did you find what you were looking for? Share feedback.